SAN FRANCISCO—WeissComm Partners, a communications firm focused on biopharmaceutical, device and diagnostic clients, has named Diane Weiser chief operating officer. Weiser joins WeissComm from Ketchum where she was director of the agency’s West Coast healthcare practice. The COO position is a newly-created position that reports directly to Jim Weiss, founder, president and CEO.
“Our clients are facing major challenges in an increasingly complex and competitive healthcare environment,” said Weiss. “Diane combines high-level strategic thinking with get-it-done determination that will be invaluable to address both product launch and crisis and issues management challenges. She also brings considerable experience in molding the best and brightest agency talent into highly-effective performance-driven teams.”
At Ketchum, Weiser was the leader for the Genentech Avastin business, managing a multi-office team, as well as providing counsel to other Genentech product teams. Prior to joining Ketchum San Francisco, she ran Ketchum’s New York healthcare practice as well as the agency’s global Lipitor business.